Drug Type ASO |
Synonyms ISTH1106 |
Target |
Action inhibitors |
Mechanism TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Phase 1 | Germany | 11 Aug 2021 | |
Nonalcoholic Steatohepatitis | Phase 1 | Germany | 11 Aug 2021 |